eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
vol. 32
Original paper

Serum IL-17A in Behçet’s disease

Nazan Emiroglu
Fatma Pelin Cengiz
Gul Bahar Erdem

Postep Derm Alergol 2015; XXXII (5): 358–361
Online publish date: 2015/10/29
View full text Get citation
Introduction: Behçet’s disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behçet’s disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.

Aim: This study evaluated the serum levels of IL-17A in active and stable Behçet’s disease patients.

Material and methods: Seventy-six patients who had active clinic findings of Behçet’s disease were enrolled in our study. Seventy age- and sex-matched controls were also enrolled. Serum IL-17 levels were studied in peripheral venous blood samples.

Results: No significant differences were found between active Behçet’s disease patients and controls in terms

of serum IL-17A (p > 0.05).

Conclusions: These results suggest that IL-17A serum levels do not play an important role in active Behçet’s disease.

active, Behçet’s disease, interleukin 17

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.